Finasteride Dose Adjustments for East Asian Patients
Evidence-based guide to finasteride dosing in East Asian populations, covering pharmacogenomic differences, CYP enzyme variants, clinical trial data, and practical prescribing considerations.
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

Showing 8 of 8 clinical reviews.
Evidence-based guide to finasteride dosing in East Asian populations, covering pharmacogenomic differences, CYP enzyme variants, clinical trial data, and practical prescribing considerations.
A clinical deep-dive into how finasteride performs differently in East Asian men and women, covering pharmacogenomics, ethnicity-stratified trial data, dosing considerations, and what the evidence means for clinical practice.
A clinician-reviewed guide to finasteride pharmacogenomics, dosing considerations, and safety differences in Hispanic and Latino patients, with ethnicity-stratified data, PharmGKB references, and practical prescribing guidance.
A clinician-focused guide to finasteride dosing, pharmacogenomics, and efficacy evidence in Black and African ancestry patients, including SRD5A2 variant data, ethnicity-stratified trial subgroups, and practical prescribing guidance.
Evidence-based review of how finasteride performs in Hispanic and Latino populations, including pharmacogenomic variants, dosing considerations, and efficacy data from clinical trials.
A clinical review of how finasteride performs in South Asian men with androgenetic alopecia, covering pharmacogenomics, SRD5A2 polymorphisms, ethnicity-stratified trial data, and dosing considerations for this population.
A clinical deep-dive into how finasteride pharmacokinetics, SRD5A genetics, and South Asian metabolic physiology interact, with practical dosing guidance reviewed by the HealthRX.com medical team.
A clinical review of finasteride pharmacogenomics, dosing considerations, and safety differences in South Asian patients, with cited trial data and guideline references.